Burkholderia pseudomallei infection in a cystic fibrosis patient from the Caribbean: A case report

Canadian Respiratory Journal

Volumn 15, Issue 5, 2008, Pages 237-239

  Corral, Dimas Mateos ^a   Coates, Allan L ^a   Yau, Yvonne C W ^a   Tellier, Raymond ^a   Glass, Mindy ^b   Jones, Steven M ^c   Waters, Valerie J ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

Acute pulmonary exacerbation; Burkholderia; Cystic fibrosis; Melioidosis; Pseudomallei

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; MULTIVITAMIN; PANCREAS ENZYME;

ADOLESCENT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BREATHING EXERCISE; BRONCHIECTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; COUGHING; CYSTIC FIBROSIS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EXPIRATORY RESERVE VOLUME; GENE AMPLIFICATION; GENE TARGETING; HAEMOPHILUS INFLUENZAE; HUMAN; LUNG INFECTION; MALE; MELIOIDOSIS; NUCLEOTIDE SEQUENCE; PNEUMONIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERUM SICKNESS; SERUM SICKNESS LIKE SYMPTOM; STAPHYLOCOCCUS AUREUS;

EID: 57449107131     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/290412     Document Type: Article

References (12)

1. Gee JE, Sacchi CT, Glass MB, et al. Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei. J Clin Microbiol 2003;41:4647-54.
2. Centers for Disease Control and Prevention. Laboratory exposure to Burkholderia pseudomallei - Los Angeles, California, 2003. MMWR Morb Mortal Wkly Rep 2004;53:988-90.
3. Wuthiekanun V, Amornchai P, Chierakul W, et al. Evaluation of immunoglobulin M (IgM) and IgG rapid cassette test kits for diagnosis of melioidosis in an area of endemicity. J Clin Microbiol 2004;42:3435-7.
4. Cheng AC, Currie BJ. Melioidosis: Epidemiology, pathophysiology, and management. Clin Microbiol Rev 2005;18:383-416.
5. Holland DJ, Wesley A, Drinkovic D, Currie BJ. Cystic fibrosis and Burkholderia pseudomallei infection: An emerging problem? Clin Infect Dis 2002;35:e138-40.
6. O'Carroll MR, Kidd TJ, Coulter C, et al. Burkholderia pseudomallei: another emerging pathogen in cystic fibrosis, Thorax 2003;58:1087-91.
7. Schülin T, Steinmetz I. Chronic melioidosis in a patient with cystic fibrosis. J Clin Microbiol 2001;39:1676-7.
8. Visca P, Cazzola G, Petrucca A, Braggion C. Travel-associated Burkholderia pseudomallei infection (Melioidosis) in a patient with cystic fibrosis: A case report. Clin Infect Dis 2001;32:E15-6.
9. Dance DA, Smith MD, Aucken HM, Pitt TL. Imported melioidosis in England and Wales. Lancet 1999;353:208.
10. Ashdown LR. Melioidosis and safety in the clinical laboratory. J Hosp Infect 1992;21:301-6.
11. Green RN, Tuffnell PG. Laboratory acquired melioidosis. Am J Med 1968;44:599-605.
12. Schlech WF III, Turchik JB, Westlake RE, Jr, Klein GC, Band JD, Weaver RE. Laboratory-acquired infection with Pseudomonas pseudomallei (melioidosis). N Engl J Med 1981;305:1133-5.